4//SEC Filing
STAHL NEIL 4
Accession 0001968202-24-000056
CIK 0000872589other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:02 PM ET
Size
16.4 KB
Accession
0001968202-24-000056
Insider Transaction Report
Form 4
STAHL NEIL
SVP Res and Dev Sciences
Transactions
- Sale
Common Stock
2024-02-07$947.34/sh−100$94,734→ 59,956 total - Sale
Common Stock
2024-02-07$949.45/sh−601$570,619→ 57,461 total - Sale
Common Stock
2024-02-07$951.49/sh−1,237$1,176,993→ 53,097 total - Sale
Common Stock
2024-02-07$953.00/sh−19$18,107→ 52,019 total - Sale
Common Stock
2024-02-07$948.69/sh−1,894$1,796,819→ 58,062 total - Sale
Common Stock
2024-02-07$950.43/sh−3,127$2,971,995→ 54,334 total - Sale
Common Stock
2024-02-07$952.49/sh−1,059$1,008,687→ 52,038 total
Holdings
- 5,834(indirect: By 401(k))
Common Stock
- 4,605(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents volume-weighted average price of sales of 1,894 shares of Company stock on February 7, 2024 at prices ranging from $948.19 to $948.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 601 shares of Company stock on February 7, 2024 at prices ranging from $949.22 to $949.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 3,127 shares of Company stock on February 7, 2024 at prices ranging from $950.00 to $950.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 1,237 shares of Company stock on February 7, 2024 at prices ranging from $951.00 to $951.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 1,059 shares of Company stock on February 7, 2024 at prices ranging from $952.03 to $952.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001226689
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:02 PM ET
- Size
- 16.4 KB